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Abstract
Background: Molecular evolution of carbohydrate binding modules (CBM) is a new approach for
the generation of glycan-specific molecular probes. To date, the possibility of performing affinity
maturation on CBM has not been investigated. In this study we show that binding characteristics
such as affinity can be improved for CBM generated from the CBM4-2 scaffold by using random
mutagenesis in combination with phage display technology.
Results: Two modified proteins with greatly improved affinity for xyloglucan, a key
polysaccharide abundant in the plant kingdom crucial for providing plant support, were generated.
Both improved modules differ from other existing xyloglucan probes by binding to galactose-
decorated subunits of xyloglucan. The usefulness of the evolved binders was verified by staining of
plant sections, where they performed better than the xyloglucan-binding module from which they
had been derived. They discriminated non-fucosylated from fucosylated xyloglucan as shown by
their ability to stain only the endosperm, rich in non-fucosylated xyloglucan, but not the integument
rich in fucosylated xyloglucan, on tamarind seed sections.
Conclusion: We conclude that affinity maturation of CBM selected from molecular libraries
based on the CBM4-2 scaffold is possible and has the potential to generate new analytical tools for
detection of plant carbohydrates.
Background
Plant cell walls rich in polysaccharides are important
targets for the food, fiber and fuel industries. Both
primary and secondary cell walls consist of a complex
network of cellulose microfibrils connected to two
different groups of polysaccharides, hemicelluloses and
pectins, which together with a lesser amount of
glycoproteins and phenolic substances interact to form
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varies largely in concentration, type and structure
between different plant species, tissues and during the
stages of plant development. Less invasive methods that
enable analysis of plant components without destroying
the network are sought as they can be used not only to
detect the presence of individual polysaccharides and
their microdistribution across cell walls but can also
reveal the organization and interactions between differ-
ent matrix-components thus helping to understand their
function. This is possible with molecular probes that
specifically detect polysaccharides in plant sections [1].
To date, antibodies dominate the field of molecular
probes but some challenges need still to be overcome.
Attempts to produce antibodies by conventional immu-
nization strategies that recognize carbohydrates are often
hampered by the low immunogenicity/antigenicity of
these macromolecules. Furthermore, antibodies in their
native form are unstable under certain conditions like
elevated temperatures, and they have a large size that
limits their penetration into samples and restricts their
use in some applications. These limitations have led to
the development and use of techniques that are
independent of immunization [2] and to approaches
using stabilized protein variants [3]. Furthermore,
alternative scaffolds [4] that are stable enough to
withstand the modulation of their molecular surface by
molecular engineering [5] are used as alternatives to
antibodies and antibody fragments to select specific
binders from large molecular libraries. Carbohydrate-
binding module (CBM) 4-2 from xylanase 10A of
Rhodothermus marinus is one such scaffold from which a
combinatorial library has been constructed through
mutagenesis of twelve amino acids in the carbohy-
drate-binding cleft [6]. From this library, binders with
novel engineered specificities targeting carbohydrates
have been selected proving the evolutionary capacity of
this scaffold.
In this study we further investigated CBM4-2 as a
diversity-carrying scaffold and explored the potential of
selected variants to undergo further evolution in vitro to
perfect their binding properties and their usefulness as
molecular probes. Random mutagenesis is a powerful
tool that can be used to create diversity from which
mutants with improved binding can be selected in a
manner similar to that exploited by the immune system
for adjusting antibody affinity and/or specificity against
a given antigen. Here we target the plant polysaccharide
xyloglucan. During plant growth, the primary cell wall
has a crucial role by providing mechanical support while
allowing cell growth and expansion. Of the hemicellu-
loses present in primary cell walls, xyloglucan is the most
abundant in dicotyledons and non-graminaceous
monocotyledons. It is built up by a cellulose-like b1-4
glucan backbone that may be substituted up to 75% with
xylose units. The xyloses in turn can be decorated with
galactose and fucose units, in the latter case generating
so-called fucosylated xyloglucan (Figure 1). Many ques-
tions still remain to be answered regarding the role of
xyloglucan. It is known that xyloglucan structure varies
slightly in different plant species [7,8] but its exact
composition for all species is unknown. Also the role
and necessity of xyloglucan during development of the
cellulose-xyloglucan network in primary cell walls is
currently under debate [9]. Moreover, recent studies
suggest that xyloglucan may play an important role in
the bending of hardwood tree by creating tensile stress in
the gelatinous G-layer found in the tension wood
[10,11]. Molecular probes specific for xyloglucan could
help to address these questions in detail.
To date, there exist two types of xyloglucan detecting
probes, polyclonal and monoclonal antibodies [12,13],
and xyloglucan-binding modules (XGBM) created by
CBM engineering [14]. In this study, designed to evaluate
the evolutionary potential of CBM by exposing a XGBM
to random mutagenesis and selection, we have generated
additional xyloglucan binding probes. The new XGBM
have higher affinity for xyloglucan compared to our
earlier reported XGBM and these bind, in contrast to
other xyloglucan detecting probes, to xyloglucan regions
that are galactose-decorated, thereby extending the
Figure 1
Xyloglucan building blocks. Schematic structures of
oligosaccharide units XXXG, XLXG, XXLG, XLLG and
XXFG that build up xyloglucan of many land plant species.
The building blocks are composed of glucosyl units (blue
circle) joined together by b1,4 linkages, to which a1,6 linked
xylosyl units (orange star) may be added. Galactose (yellow
circle) and fucose (red triangle) are incorporated into these
structures via b1,2 and a1,2 linkages, respectively.
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usefulness in applications such as studies of plant cell
wall organization.
Methods
Carbohydrates
Non-fucosylated xyloglucan derived from seeds of
Tamarindus indica,l a m i n a r i n ,l i c h e n a na n dg a l a c t o s e
were derived from Megazyme (Bray, Ireland) while
birchwood xylan was purchased from Sigma-Aldrich
(St. Louis, MO, USA). Biotinylated xyloglucan was
prepared as previously described [14]. Biotinylated
fucosylated xyloglucan was prepared from fucosylated
xyloglucan derived from Rubus fructicosus (kindly pro-
vided by Gérard Chambat, CERMAV-CNRS, Grenoble,
France), as previously described [14].
Library construction
The gene encoding XG-34 [GenBank:DQ279274], a
XGBM previously described [14], was used as starting
material when creating two xyloglucan focused CBM
libraries (hereafter referred to as Lib1 and Lib2).
Mutations were randomly introduced by using the
PCR-based Genemorph II Random Mutagenisis Kit
from Stratagene (La Jolla, CA, USA) and following the
manufacture’s instructions for achieving a mutation ratio
of 1%. In a first round of mutations XG-34 was used as
template gene to create Lib1, which in turn was
submitted to a second round of mutations to create
Lib2. Both PCR-products were purified (from 2% agarose
gels) using a commercial kit (QIAquick Gel Extraction
Kit, Qiagen, Hilden, Germany), digested with SfiIa n d
NotI (both from New England Biolabs, Beverly, MA,
USA) and purified again before cloning between SfiI/
NotI sites of a modified version of the pFab5c.His [6]
phagemid vector. The ligated products were transformed
into electrocompetent Escherichia coli Top10F’ (Invitro-
gen, Carlsbad, CA, USA) that were grown on Luria-
Bertani (LB) agar plates (15 cm Ø) containing selective
antibiotics (100 μg/ml ampicillin, 10 μg/ml tetracycline
and 1% (w/v) glucose). The cultivated cells were
gathered and stored at -80°C in 15% glycerol and
colonies selected at random for sequence-analysis to
determine the diversity of each library.
Phage stocks were produced by infecting cultures of the
bacteria harbouring the library grown in 2× Yeast
Tryptone (2YT) media containing 100 μg/ml ampicillin,
10 μg/ml tetracycline and 1% (w/v) glucose at exponen-
tial growth phase with VSCM13 helper phage (Strata-
gene) at a multiplicity of infection of 20:1 during 30 min
at 37°C without shaking. The growth medium was
changed and the glucose was replaced by 0.25 mM
isopropyl-b-D-thiogalactoside (IPTG) and 50 μg/ml
kanamycin and production of phage particles was
allowed to proceed over night at 30°C with shaking.
Finally the phages were precipitated by incubation on ice
of filtered supernatants with 0.25 volumes 20%
PEG6000/2.5 M NaCl followed by centrifugation
(13,000× g, 30 min, 4°C). The pellets were dissolved
in PBS containing 0.1% BSA (Sigma-Aldrich) in a tenth
of the original culture volume and stored at 8°C.
Phage display selection
Selections were performed in three rounds using
streptavidin-coated paramagnetic Dynabeads (Dynal,
Oslo, Norway). Every selection round was preceded by
an incubation step, in which phages that bind non-
specifically to the beads or that recognize the major
substrate, i.e. xylan, of CBM4-2 were removed. In short,
500 μl of library phage-stocks were incubated in
selection buffer (PBS, 1% BSA and 0.05% Tween 20)
with 50 μl streptavidin-coated Dynabeads, i.e. beads
without xyloglucan, and 400 μl xylan (soluble fraction of
100 mg xylan dissolved in 5 ml PBS). The beads were
removed using a magnetic holder and the remaining
supernatant was used for selections. In a parallel step
Dynabeads were coated with biotin-conjugated xyloglu-
can. Different amounts of beads and xyloglucan were
used in the different rounds of selection. In the first
round 50 μl beads were coated with 2 μg biotin-labelled
xyloglucan for 30 minutes before excess xyloglucan was
removed by washing. The washed xyloglucan-coated
beads were mixed with the supernatants from the
preincubation step and left for incubation during
2 hours on an end-to-end rotor. Next, unbound phages
were removed by washing four times with selection
buffer and then twice with PBS. The bound phages were
eluted by digestion with 100 μlo f0 . 5m g / m lt r y p s i n
during 30 min after which the reaction was stopped by
addition of 100 μl of 0.1 mg/ml aprotinin. Finally the
eluted phages were rescued by infecting them into E. coli
Top10F’ at exponential growth phase during 30 min at
37°C. Bacteria were spread on selective media (LB-agar
plates, 100 μg/ml ampicillin, 10 μg/ml tetracycline and
1% (w/v) glucose) and grown over night at 37°C. The
second round of selections differed by reduction of the
a m o u n to fl i g a n dt o5μl Dynabeads coated with 0.01 μg
xyloglucan. In the third round of selections two different
strategies were used. First, after preincubation of phage
stocks with streptavidin-coated Dynabeads and soluble
xylan, 0.01 μg biotin-xyloglucan was added to the phage
stock. After a 30 minutes incubation at room tempera-
ture, 5 μl streptavidin-coated Dynabeads were added
with or without concomitant addition of soluble
xyloglucan (1.4 μg) as a competitor. The third round
of selections generated four pools of phages (two each
from Lib1 and Lib2) from which 40 colonies (10 from
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phage ELISA and by sequencing. Isolated clones were
named XG-34 followed by an Arabic number to define
its library origin (Lib1 or Lib2) and a roman numeral to
define the clone number (selected with (I-X) or without
(XI-XX) added soluble xyloglucan during the final stages
in the third round of selection).
Phage ELISA
Binding of phage-displayed CBM towards xyloglucan
and xylan was studied by ELISA. 96-well microtitre plates
(Nunc, Roskilde, Denmark) were coated over night with
strepavidin (0.2 μg/ml) or xylan (100 μl of the soluble
fraction of 100 mg xylan dissolved in 11 ml PBS).
Biotinylated xyloglucan (0.2 μg/ml) was added onto the
streptavidin-coated plates. Phage stocks diluted in
selection buffer were added to the plates in duplicates.
After incubation for 2 hours at 37°C unbound phages
were washed off and bound phages were detected using
horseradish peroxidase-conjugated anti-M13 antibody
(Amersham Pharmacia Biotech Inc., Piscataway, NJ,
USA) diluted in blocking buffer. The plates were
analyzed with o-phenylenediamine as chromogen
whose development was quantified using an Emax
spectrophotometer (Molecular Devices, Sunnyvale, CA,
USA) at 490 nm, once the reaction had been stopped
with H2SO4. In primary screening of clones, those that
gave an absorbance > 0.2 against xyloglucan were
considered to display XGBM.
Sequence analysis
Sequencing was performed by Eurofins MWG Operon
(Ebersberg, Germany) using plasmids purified from over
night cultures using QIAamp DNA Mini Kit (Qiagen) as
the sequencing template. Gene sequences have been
deposited in GenBank [GenBank:FJ556578 (XG-34/1-X);
GenBank:FJ556579 (XG-34/2-I); GenBank:FJ556580
(XG-34/2-VI)]. A structure model of XG-34/I-X was
obtained using the CPHmodels 2.0 homology-model-
ling server http://www.cbs.dtu.dk/services/CPHmodels/
using the structure of CBM4-2 [PDB:1k42] as template,
as described by Cicortas Gunnarsson et al [15].
Site-directed mutagenesis
Single mutations in the XG-34 and XG-34/2-VI genes
were introduced using QuickChange II Site-Directed
Mutagenesis Kit (Stratagene) according to the manufac-
turer’s protocol with one exception. Instead of using NZY
Broth when recovering transformed E. coli XL1-Blue cells
2YT was used. To mutate XG-34 aspartate at position 112
into glutamate, primers 5’-GAATCAGTCGCATGATGAA-
TACGGGAGACTGCATG-3’ (forward) and 5’-CATG-
CAGTCTCCCGTATTCATCATGCGACTGATTC-3’(backward)
were used. In the same way a primer-pair consisting of
5’-GAATCAGTCGCATGATGATTACGGGAGACTGCATG-
3’ (forward) and 5’-CATGCAGTCTCCCGTAATCAT-
CATGCGACTGATTC-3’ (backward) were used for muta-
tion of the same residue (112) from glutamate to
aspartate in XG-34/2-VI. Primers were obtained from
Eurofins MWG Operon.
Protein production
Production of soluble CBM was performed using the T7
expression-system consisting of the pET22b vector
(Novagen, Madison, WI) harboured in E. coli BL21
(DE3). Restriction-sites were introduced before and after
CBM-encoding genes with the help of PCR according to
Cicortas Gunnarsson et al [6]. Digestion of purified PCR-
products and pET22b with NdeIa n dXhoI (both from
New England Biolabs) enabled cloning of the genes in-
between NdeI/XhoI sites in the vector resulting in
constructs encoding recombinant proteins containing a
hexahistidine tag. The ligated products were transformed
into chemically competent E. coli BL21 (DE3) from
which production of recombinant CBM was controlled
with glucose/IPTG. CBM-producing bacteria were cul-
tured in 2YT media containing ampicillin (100 μg/ml) to
exponential phase (OD600 = 0.3-0.5) before protein-
production was induced by addition of IPTG (0.25 mM
final concentration) and allowed to proceed for 3 hours
at 37°C. Cells were harvested by centrifugation (6000×
g, 15 min), washed with cold 0.9% NaCl and resus-
pended in 20 mM NaH2PO4/ 0 . 7 5MN a C l ,p H7 . 4 .C e l l -
lysates were centrifugated (13,000× g, 15 min) after
sonication (3 × 2 min, 50% amplitude (250-D sonifier;
Branson Ultrasonics Corp., Danbury, CT, USA)) and the
CBM were finally purified on columns containing
Ni-NTA (Qiagen) using immobilized metal affinity
chromatography. The concentration of purified CBM
was determined spectrophotometrically from absor-
bance measurements at 280 nm using extinction
coefficients individually calculated for each CBM using
the ProtParam software [16] available at http://www.
expasy.org.
Binding analysis
Affinity electrophoresis (AE) was done using polyacryla-
mide gels containing different carbohydrates. The gels
used for separation were cast from carbohydrate-solu-
tions containing 12.5% acrylamide/bisacrylamide (29:1)
in 0.75 M Tris, pH 8.8. On top of each separation gel
a stacking gel (3% acrylamide/bisacrylamide (29:1),
0.25 M Tris, pH 6.8) was cast. All gels were run using
the Bio-Rad (Hercules, CA, USA) mini-gel system at
room temperature at 90 V in running buffer (0.025 M
Tris/0.192 M glycine, pH 8.3). The migration speed of
native soluble CBM was performed using 3 μgp r o t e i n
per lane. The carbohydrates embedded in the gels
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(0.125-2 mg/ml), laminarin (1 mg/ml) and lichenan
(0.5 mg/ml). The proteins were visualized by Simply-
Blue-staining (Invitrogen). A standard Kaleidoscopic
protein-ladder (Bio-Rad) was included in the analysis
as well as two earlier described CBM that served as
controls, X-2 [15] that recognizes xylan but not
xyloglucan, and G-4 [17] that does not bind to
carbohydrates.
Competitive ELISA was performed to study how binding
of CBM to immobilized xyloglucan was inhibited by pre-
incubation with (biotinylated) xyloglucan and fucosy-
lated xyloglucan. The inhibitory concentration required
to reduce the signal by 50% (IC50) for the different
variants was calculated. Flat-bottom 96-well plates
(Nunc) were coated with 100 μl5 0n Mx y l o g l u c a n
over night at 4°C. XG-34 and its evolved variants were
incubated with different concentrations of xyloglucan or
fucosylated xyloglucan dissolved in PBS, 1% BSA, 0.05%
Tween 20 during 1 hour at 37°C prior to transfer of the
CBM-carbohydrate solutions to the xyloglucan-coated
plates. Detection of CBM bound to immobilized
xyloglucan was achieved by using horseradish perox-
idase-conjugated anti-His6 antibody (Roche Diagnostic
Corporation, Indianapolis, IN). Development of the
plates was done as described above for phage ELISA.
Isothermal titration calorimetry (ITC) measurements
were performed at 25°C following standard procedures
[18] using a Microcal Omega titration calorimeter
(Northampton, MA, USA). XXXG and XLLG (Figure 1)
were prepared as previously described [19]. Prior to
analysis, the CBM were extensively dialyzed against
20 mM HEPES, pH 8.0 containing 2 mM CaCl2.T h e
same buffer was used to dissolve tamarind seed
xyloglucan, XXXG, XLLG and galactose to minimize
heats of dilution. 50 μM protein samples were stirred at
300 rpm in a 1.4331 ml reaction cell. Ligands were
injected as a single 1 μl aliquot followed by 27 successive
10 μla l i q u o t sa t3 0 0si n t e r v a l s( 2m M ,7 . 5m Mo r
10 mM XXXG; 1 mM or 5 mM XLLG; 2.5% or 5% w/v
xyloglucan; 10 mM galactose). Integrated heat effects
were analyzed by non-linear regression using a single-
site binding model.
Plant tissue labelling with CBM and antibodies
Dry tamarind seeds were scarified and left overnight in
water at room temperature (rt). The next day, swollen
seeds were shelled and cut into ca 15 μms e c t i o n su s i n ga
Leitz microtome (Leica Mikrosystems GmbH, Wetzlar,
Germany) microtome. All labelling experiments were
thereafter performed three times with sections placed in
Eppendorf tubes. In order to prevent non-specific
binding of CBM, sections were treated with a blocking
solution containing 5% (w/v) ovalbumin in 50 mM
sodium phosphate buffer (pH 7.4) for 1 h at rt followed
by washing (twice, 15 minutes) in the same buffer.
Tamarind sections were incubated with FITC-conjugated
[20] CBM at 0.1-10 μM for 1 and 4 h (at rt) and
overnight (+4°C). Thereafter samples were washed three
times with buffer (10 minutes each step). Additional
sections were labelled with fucosylated xyloglucan-
specific FITC-conjugated CBM FXG-14b (Cicortas Gun-
narsson et al, unpublished data) at a concentration of
2 μMi n5 0m Ms o d i u mp h o s p h a t eb u f f e r( p H7 . 4 )u s i n g
the same labelling protocol.
Blocked tamarind sections were also incubated with
monoclonal antibody CCRC-M1 [13] at a 1:10 dilution
in 50 mM sodium phosphate buffer (pH 7.4) supple-
mented with 1% ovalbumin overnight (+4°C). After
washing (twice, 20 minutes each, rt with slight stirring),
samples were labelled with FITC-conjugated anti-mouse
antibody (Sigma-Aldrich) at a 1:500 dilution for 1 h at rt
a n dw a s h e dw i t hw a t e r .
Fluorescent microscopy
Samples were placed on object glasses mounted in
Fluorsave (Calbiochem), covered by coverslips and
examined by fluorescent microscopy using a standard
set of filters for FITC. All images were obtained using a
Leica DC300F CCD camera and digital imaging system
for professional microscopy (Leica Microsystems GmbH)
at equal settings (magnification ×40, exposure time 1 s
and gain 3.2).
Results
Library construction
We have previously reported on the molecular engineer-
ing of xyloglucan-specific binders using the scaffold of a
carbohydrate-binding module CBM4-2 from the xyla-
nase 10A of R. marinus. In this study we show that it is
possible to evolve (Figure 2) the functionality of binders
based on this scaffold as exemplified by one such
module, XG-34 specific for non-fucosylated xyloglucan
[14] while preserving its specificity for xyloglucan.
Through random mutagenesis, two libraries (Lib1 and
Lib2) each consisting of 1-3 × 10
7 clones were created by
cloning of mutated genes in a modified version of the
pFAB5c.His phagemid vector [6] that is suited for use in
phage display selection approaches. Sequencing of 23
clones randomly selected from each library revealed that
60% and 35% respectively, of members of Lib1 and Lib2
had inserts, out of which approximately 86% and 54%
BMC Biotechnology 2009, 9:92 http://www.biomedcentral.com/1472-6750/9/92
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substitutions was 0.8-1.0%.
Selection and primary screening
The combinatorial libraries were used separately for
selection of tight xyloglucan-binding clones by phage
display. Three rounds of selections were performed in
the presence of xylan using biotinylated xyloglucan
bound to streptavidin-coated Dynabeads as the target.
The selection pressure was increased in two subsequent
rounds of selection by decreasing the amount of
biotinylated xyloglucan. In the last round of selection
preformed biotinylated xyloglucan-phage-complexes
were caught on streptavidin coated paramagnetic beads
i nt h ep r e s e n c eo ra b s e n c eo fs o l u b l ex y l o g l u c a ni na n
attempt to vary the degree of selection stringency further.
The selection system generated two pools of clones for
each library. From each pool, 10 clones were randomly
picked and analyzed with phage-ELISA using xylan or
xyloglucan as target. Of these 40 clones, 31 bound
xyloglucan. Among these, the six clones that bound best
to xyloglucan in comparison to XG-34 and only showed
low binding to xylan were selected. Subsequent analysis
of the ability of soluble xyloglucan to inhibit the binding
of these XGBM displayed on phage to immobilized
xyloglucan, identified three clones with improved
properties (Figure 3). These variants, XG-34/1-X
(selected from Lib1) and XG-34/2-I and XG-34/2-VI
(selected from Lib2), were all identified from the
selections in which soluble xyloglucan had been
incorporated in the final stages of the third round of
selection.
Affinity and specificity
The binding characteristics of the three variants of XG-34
in soluble form were analyzed by AE. Retardation in
xyloglucan-containing gels was considerably higher for
two of the evolvants, XG-34/1-X and XG-34/2-VI, than
for XG-34 indicating improved affinity for these mod-
ules. The third mutant, XG-34/2-I behaved similar to
XG-34. To assess the specificity of the new clones we
performed AE-studies with laminarin, lichenan and
different concentrations of xylan. None of the novel
clones bound to any of these substrates demonstrating
that polyreactive binding properties had not developed
as a consequence of the affinity maturation process
(Figure 4).
Binding affinities exhibited by XG-34, XG-34/1-X and
XG-34/2-VI towards xyloglucan and the component
Figure 2
CBM selection and evolution scheme. Scheme showing the route of CBM evolution. Targeted mutagenesis of 12 codons
encoding the carbohydrate-binding cleft of CBM4-2 resulted in a first library displayed on phage [6] from which the XGBM
XG-34 was isolated [14]. Random PCR-based mutagenesis of the gene encoding XG-34 resulted in second generation phage
display libraries from which matured variants of XG-34 could be selected by a stringent selection procedure (this
investigation).
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(galactose-containing) (Figure 1) were determined by
ITC. For XG-34, binding was clearly detectable but too
low to be precisely quantified. In contrast, the evolvants
XG-34/1-X and XG-34/2-VI bound well to XLLG in an
enthalpy-driven interaction, with affinities in the KA =
10
5 M
-1 range, but not to the non-galactosylated
oligosaccharide XXXG (Table 1). These modules also
bound notably stronger to xyloglucan than XG-34,
however still below the limits of precise quantification
by ITC. The fact that these modules bind well to XLLG
but not to XXXG suggests that the galactose decorations
of the xyloglucan polymer play an important role in the
binding of the module to the ligand. Further ITC
experiments showed that neither XG-34/1-X nor XG-
34/2-VI bind to galactose monosaccharides, strongly
suggesting that a more specific, ordered pattern of the
galactose decorations provide a necessary motif for
proper ligand recognition and binding.
To further define the specificity of the two tight-binding
mutants we investigated if these possessed, like XG-34,
the ability to discriminate xyloglucan from its fucosy-
lated form. Competition ELISA was performed by
inhibiting binding of XG-34/1-X and XG-34/2-VI to
biotinylated xyloglucan on plates by preincubation with
different concentrations of soluble (biotinylated) xylo-
glucan or fucosylated xyloglucan. XG-34/1-X and XG-34/
2-VI were efficiently inhibited from binding immobi-
lized xyloglucan by addition of soluble xyloglucan with
an IC50-value of 5 ng/ml and 3 ng/ml, respectively. To
achieve the same degree of inhibition approximately 30-
fold more fucosylated xyloglucan was needed (Figure 5),
revealing that the ability of XG-34 to discriminate
between these forms of xyloglucan had been retained
during the affinity maturation process.
Sequence analysis
Sequencing revealed that XG-34/1-X, XG-34/2-I and XG-
34/2-VI carried 2-6 substitutions at the amino acid level
in comparison to XG-34. They had one mutation in
common, a substitution of aspartate in position 112 to
glutamate (Asp
112 Æ Glu). This substitution reverses a
mutation of XG-34 to the residue found in CBM4-2
(Figure 6). Besides this mutation XG-34/1-X and XG-34/
2-VI, the two tight-binding clones, had only one other
mutation each, both of which were located in two
adjacent loops far away from the carbohydrate binding-
site. The number of substitutions found in the third
clone, XG-34/2-I was greater as it had incorporated 6
altered residues (Figure 6).
Mutagenesis of residue 112
To evaluate the significance of glutamate in position
112, a Glu
112 Æ Asp mutant of XG-34/2-VI and an
Asp
112 Æ Glu mutant of XG-34 were produced. Affinity
electrophoresis demonstrated that XGBM containing
glutamate in position 112 i.e. XG-34/2-VI and XG-34
Figure 3
Specific binding. Binding of individual clones by phage-
ELISA. Binding to immobilised biotin-labeled xyloglucan was
inhibited by pre-incubation of XGBM-displaying phage clones
with either soluble xyloglucan or xylan. The binding of three
clones, XG-34/1-X (squares), XG-34/2-I (triangles) and XG-
34/2-VI (circles), was inhibited by xyloglucan (filled symbols)
but not by xylan (open symbols).
Figure 4
Carbohydrate binding specificity. AE in polyacrylamide
gels polymerized in the presence of no substrate, 0.5 mg
xyloglucan/ml, 1.0 mg xylan/ml, 0.5 mg lichenan/ml or 1.0 mg
laminarin/ml. The arrow indicates the direction of migration
in the gels. The evolved modules XG-34/1-X and XG-34/2-VI
exhibited efficient binding to xyloglucan while XG-34/2-I
bound slightly better than XG-34 and CBM4-2. The evolved
clones do not show affinity for the other polysaccharides
indicating that the specificity for xyloglucan was retained
during the affinity maturation process. The first lane contains
a kaleidoscopic protein-ladder to monitor gel migration and
in the last lane an evolved xylan-specific CBM, X-2 [15]
serves as a control.
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proteins having an aspartatei np o s i t i o n1 1 2( X G - 3 4a n d
XG-34/2-VI E112D) bound xyloglucan with low affinity
(Figure 7). Thus, the glutamate in position 112 alone is
responsible for the increased apparent affinity of XG-34/
2-VI for xyloglucan and it is likely to have a significant
effect on the affinity of XG-34/1-X and XG-34/2-I as well.
As none of these proteins with aspartate or glutamate in
this position, in contrast to CBM4-2, show any binding
to xylan, it appears that other common differences (in
positions 69, 72, 76, 110, 111, 149) in the sequence of
XG-34 and its mutants in comparison to CBM4-2 are
likely to contribute to this binding character. Thus, these
other modifications provide the framework in which
Table 1: Binding affinity constants (KA) and thermodynamic properties of XGBM-carbohydrate interactions*
Module Carbohydrate
xyloglucan XXXG XLLG
† galactose
KA
(10
3 M
-1)
KA
(10
3 M
-1)
KA
(10
3 M
-1)
ΔG
(kcal mol
-1)
ΔH
(kcal mol
-1)
TΔS
(kcal mol
-1)
n
§
XG-34 ≈ 0.1 ≈ 1 ≈ 1- - - - n o t d e t e r m i n e d
XG-34/1-X ≈ 10 ≈ 1 147 ± 6 -7.0 ± 0.1 -15.8 ± 0.1 -8.8 ± 0.1 1.0 ± 0.0 no binding
XG-34/2-VI ≈ 10 ≈ 1 141 ± 4 -7.0 ± 0.0 -14.0 ± 0.1 -7.0 ± 0.1 1.1 ± 0.0 no binding
*Thermodynamic parameters for some interactions could not be fully characterized due to relatively low affinity, limited solubility of protein and
limited availability of ligand. In those cases n was fixed to 1 for data fitting and calculation of KA.
†ITC thermograms are available as supplementary information [see Additional file 1].
§calculated number of binding sites on the protein.
Figure 5
Carbohydrate binding specificity. Inhibition of binding of
XG-34/1-X (A) and XG-34/2-VI (B) to immobilized
xyloglucan by either soluble fucosylated xyloglucan (filled
circles) or non-fucosylated xyloglucan (empty squares).
Figure 6
Protein sequences. Sequence alignment of XG-34, the three evolved modules XG-34/1-X, XG-34/2-I and XG-34/2-VI and
CBM4-2. Residue numbering is in agreement with Simpson et al [22]. Dots indicate identity with XG-34 sequence. The close
proximity of residue 112 (green), mutated in evolved variants of XG-34, to residues 110 (blue) and 69 (red) that are important
for carbohydrate binding in proteins based on the scaffold [15,22], is highlighted on a structure model of XG-34/1-X.
Figure 7
Asp/Glu
112 and binding affinity. AE of XGBM XG-34/2-VI
and Asp
112 Æ Glu-mutated XG-34 that both contain
glutamate in position 112 demonstrate that they bind
stronger to xyloglucan than their aspartate-containing
counterparts. None of these modules show binding to xylan
that is recognized by the xylan-specific module X-2 [15]. The
arrow indicates the direction of migration in the gels.
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112 is able to mediate specific high affinity binding to
xyloglucan.
D e t e c t i o no fx y l o g l u c a ni nt a m a r i n ds e e d s
An improvement in binding to a target of interest can
potentially translate into improved performance of the
probe in various applications. We explored how these
xyloglucan-specific variants derived from the CBM4-2
scaffold behaved in the staining of endosperm of tamarind
seeds, a source rich in non-fucosylated xyloglucan. As
demonstrated in Figure 8, the evolution process had
succeeded in creating variants that demonstrated more
intense staining in an immunofluorescence application. In
addition, the time of labelling did not affect signal intensity
(i.e. after 1 h it was similar to 4 h and overnight labelling)
suggesting a rapid and specific binding to non-fucosylated
xyloglucan. Staining intensity of the CBM was also stable
over at least 1 week after storage at 4°C. Importantly, the
specificity of the modules for non-fucosylated xyloglucan
could be confirmed as the tamarind seed integument rich
in fucosylated but not non-fucosylated xyloglucan, was
not stained by XG-34 or by modules evolved from it
(Figure 9A-C). In contrast, other reagents specific for
fucosylated xyloglucan stained the tamarind seed integu-
ment but not the endosperm (Figure 9D-E)
Discussion
In the search for analytical probes we have focused on
investigating the potential of CBM4-2 as an alternative to
the antibody scaffold for molecular engineering of
modules with novel binding characteristics. We have in
previous studies created a combinatorial library on the
CBM4-2 scaffold [6] from which modules that specifi-
cally bind different plant polysaccharides have been
selected, e.g. XG-34 that recognizes only non-fucosylated
xyloglucan [14]. In the present study we show for the
first time that modules with the CBM4-2 scaffold can be
further evolved using random mutagenesis in order to
gain new binding properties such as improved affinity.
This indicates a plasticity of the CBM4-2 scaffold and
demonstrates its capacity for forced evolution.
The study resulted in the generation of three new
xyloglucan-binding modules, XG-34/1-X, XG-34/2-I
and XG-34/2-VI. Compared to existing xyloglucan
probes such as monoclonal antibodies LM15 [12] that
primarily binds to the non-galactosylated xyloglucan
unit XXXG, and CCRC-M1 [13] that recognizes only
fucosylated xyloglucan, our high affinity binders differ
Figure 8
Tamarind seed xyloglucan binding. Staining of tamarind
seed tissue sections using fluorescein-labeled XGBM as
probes. The probes were used at 200 (A), 40 (B), 20 (C),
4( D )a n d2( E )μg/ml. F illustrates the lack of staining with a
protein-specific module that does not bind plant
carbohydrates, G-4 [17] developed from the CBM4-2
scaffold, at 200 μg/ml. All sections were scanned with the
same settings resulting in oversaturation of the signal
for the best XGBM at the highest concentrations.
Bar lines = 200 μm
Figure 9
Tamarind seed endosperm specificity.S p e c i f i c i t yo f
staining as illustrated by the inability of XGBM XG-34/1-X to
stain tamarind seed integument (arrows) that is rich in
fucosylated xyloglucan. Images show a section seen under
visible light (A), the fluorescence of the same section (B) and
a merged image thereof (C). While the module stained
endosperm cells, the integument cells covering endosperm
remained unstained. As a control, integument cells stained
well with the monoclonal antibody CCRC-M1 (D) and the
CBM FXG-14b (E) that are both specific for fucosylated
xyloglucan. XGBM XG-34, XG-34/2-I and XG-34/2-VI all
showed a staining pattern similar to that of XG-34/1-X
(data not shown). Bar lines = 200 μm
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XLLG, and by discriminating non-fucosylated from
fucosylated xyloglucan. Unfortunately, other xylogluco-
oligosaccharides like XLXG and XXLG that may be
present in non-fucosylated xyloglucan could not be
assessed by ITC as they were not available in sufficient
quantities in pure form preventing a more complete
specificity analysis. Nevertheless, the combined data
demonstrates a specificity of these modules different
from the other existing probes. Besides having higher
affinity than XG-34 for soluble xyloglucan, the new
binders also stained plant tissues from tamarind seed
more intensely at high protein concentration and were at
least equivalent at lower concentrations. These qualities
demonstrate that the evolution achieved a molecular
c h a r a c t e rt h a tt r a n s l a t e di n t oa ni m p r o v e dp e r f o r m a n c e
in terms of staining intensity in an analytical setting. The
enhanced labelling may be a consequence of a higher
affinity of the evolved variants not only for soluble
xyloglucan, as assessed by ITC, but also for some
xyloglucan structures in these samples. More specifically,
enhanced staining may be a consequence of a slightly
modified fine specificity increasing the number of
structures recognized in the tissue. Indeed, molecular
evolution of antibodies, the golden standard of binding
probes, has been shown to be accompanied by such
specificity fine-tuning [21]. Altogether, the improved
xyloglucan-binding modules can readily be utilized for
xyloglucan recognition in plant sections and due to their
novel binding properties that differentiate them from
other xyloglucan probes, they provide a novel set of
analytical tools, complementary to the existing ones.
One feature of the evolved xyloglucan binders is that all
contained one mutation in common (aspartate to
glutamate in position 112) compared to XG-34. This
mutation was shown to be crucial for the gained affinity
for one of the modules. Unfortunately, attempts to
obtain crystal complexes of the CBM evolvants with
xylogluco-oligosaccharides have so far been unsuccess-
ful. Consequently, the detailed structural role of the
critical residue 112 in xyloglucan recognition is not fully
understood. Residue 112 is however most likely a
residue that directly contacts carbohydrate ligands. In
the wild type CBM4-2 and in models of evolved variants
of XG-34, the side chain of this residue is oriented
towards the cavity into which carbohydrates are likely to
bind [22] (Figure 6) [see Additional file 1] and NMR
signals from the backbone amide of residue 112 shifts
upon addition of either xylopentaose or cellohexaose
[15] suggesting that it is involved in ligand binding.
Similarly, the side chain of this residue has been shown
to be located in immediate proximity to the ligand in
recently solved structures of a xylan-specific variant in
complex with oligoxylose (von Schantz et al,
unpublished data). It thus appears that the evolution
process targeted a residue directly involved in ligand
interaction. This is in contrast to antibodies whose
evolution has often shown to result from mutations in
the periphery or outside the binding-cleft both in vivo
and in vitro [23-26]. Future evolution studies will have to
confirm whether this is a general evolutionary pathway
for variants originating from the CBM4-2 scaffold or if
mutations distant from the binding-cleft also are, as they
are for antibodies, capable of fine-tuning ligand-binder
affinity. Glu
112 in combination with other mutations
present in XG-34/2-I (Val
32 Æ Glu, Val
80 Æ Ile, His
110 Æ
Gln, Gln
119 Æ Leu, Thr
129 Æ Ala) did not however result
in an improved affinity, suggesting that one or several of
these other mutations counteract the contribution in
affinity for xyloglucan promoted by Glu112. One of the
mutated residues, 110, is a critical residue in the binding
site of CBM4-2 [22]. This modification may thus be a
major contributor to the relatively poor affinity of XG-
34/2-I despite the presence of the Asp
112 Æ Glu
modification in this module.
The selection strategy involving capturing of biotinylated
xyloglucan-phage complexes in the presence of soluble
xyloglucan was successful as all three evolved CBM were
extracted from the libraries by applying this methodol-
ogy. Thus, stringent conditions appeared to be required
to find specific XGBM variants with higher affinity from
libraries created from the CBM4-2 scaffold. This is in
concordance with antibody phage methodology where it
is known that binders with different characteristics can
be identified by choosing different selection conditions
[27]. Thus, the same rules appear to apply to the
selection of specific binders derived from the CBM4-2
scaffold, a fact that can be exploited to find binders
optimal for a given application.
Conclusion
In conclusion, our study shows that the binding
characteristics, such as binding affinity, of modules
selected from molecular libraries created on the CBM4-
2 scaffold can be further improved by a molecular
evolution process. This evolution resulted in the creation
of three novel xyloglucan binders, out of which two
showed greatly improved affinity for xyloglucan. The
variants have a defined specificity, as they could be
shown to specifically target galactose-decorated xyloglu-
can structures (such as XLLG). In this respect, the two
high affinity modules XG-34/1-X and XG-34/2-VI differ
substantially from existing xyloglucan binders and
constitute a novel analytical instrument for xyloglucan
detection in plant sections. The great flexibility that can
be applied to selection from phage-display libraries
provides the scientist a substantial advantage over
BMC Biotechnology 2009, 9:92 http://www.biomedcentral.com/1472-6750/9/92
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search for binders with selected and defined properties.
We envisage that the use of these technologies will
provide a wide repertoire of defined reagents, important
for the detailed analysis of plant tissues and plant-
derived industrial material in the future.
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